EUVIMEDEUVIMED entdecken
Open Access

Accelerated Epigenetic and Inflammatory Aging and Intrinsic Capacity

Laure Rouch, Philipe De Souto Barreto, Yves Rolland, Sophie Guyonnet, Philippe Cestac, Wan-Hsuan Lu, Jean-Marc Lemaitre, Paul Bensadoun, David Furman, Bruno Vellas, Sandrine Andrieu, IHU HealthAge INSPIRE/Open Science group

JAMA Network Open · 2026

DOI: 10.1001/jamanetworkopen.2026.24102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, 2026. Verfasst von Laure Rouch und 11 weiteren Autor:innen. Beteiligte Einrichtung: IHU HealthAge, Toulouse, France. Hauptthemen laut MEDLINE: Aging, Epigenesis, Genetic, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Extending the health span requires shifting from disease-centered to preventive, function-oriented medicine. To support healthy longevity, the World Health Organization (WHO) developed intrinsic capacity (IC), a composite of physical and mental capacities an individual can mobilize; however, molecular drivers of age-related IC decline remain poorly understood.

Objective

To investigate cross-sectional and longitudinal associations of accelerated epigenetic and inflammatory aging with global IC and, secondarily, to examine domain-specific IC, sex differences, and interactions between epigenetic and inflammatory aging. Design, Setting, and Participants This population-based cohort study included participants aged 20 years or older from the longitudinal INSPIRE Lifespan Translational Cohort. The 3-year prospective cohort study was initiated in October 2019. Data analysis was conducted from June to December 2025. Exposures At baseline, accelerated epigenetic aging was measured using Horvath Pan Tissue, Horvath Skin and Blood, Hannum, PhenoAge, and GrimAge clocks; accelerated inflammatory aging was measured with the iAge clock. Main Outcomes and Measures Global IC was operationalized as a 5-domain construct: cognition (Mini-Mental State Examination), mobility (Short Physical Performance Battery), psychology (Patient Health Questionnaire for depression), vitality (grip strength), and sensory (WHO simple eye chart; whisper test) capacity and evaluated annually.

Results

Among 970 participants (median [IQR] chronological age, 64 [48-77] years; 602 [62.1%] female) with a median (IQR) follow-up time of 3.01 (2.97-3.04) years, accelerated epigenetic aging was associated with lower global IC, with a greater detrimental outcome associated with advancing chronological age (interaction with linear: β = −1.17; 95% CI. −2.02 to −0.33; false-discovery rate [FDR]–adjusted P = .04) and quadratic (β = −0.39; 95% CI, −0.71 to −0.08; FDR-adjusted P = .04) terms of chronological age. Accelerated inflammatory aging showed comparatively weaker associations with lower global IC across aging (eg, interaction with linear chronological age: β = −0.45; 95% CI, −0.77 to −0.12; FDR-adjusted P = .04). The co-occurrence of both biological aging processes resulted in greater functional impairment. The greater detrimental association of accelerated epigenetic aging with global IC was evident predominantly in male participants. In domain-specific IC analyses, mobility showed the greatest vulnerability. Conclusions and Relevance In this cohort study of participants spanning the adult lifespan, accelerated epigenetic aging was associated with lower global IC, with a greater detrimental outcome as chronological age advanced. Accelerated inflammatory aging showed weaker associations. These findings have meaningful implications for precision medicine, highlighting the potential of biomarkers derived from epigenetic and, to a lesser extent, inflammatory aging clocks to support early identification of high-risk individuals and guide targeted healthy longevity interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingEpigenesis, GeneticInflammationHumansFemaleMaleAgedMiddle AgedCross-Sectional StudiesProspective StudiesLongitudinal StudiesAdultCognitionLongevity

Autor:innen und Institutionen

  • IHU HealthAge, Toulouse, France.
  • CERPOP UMR 1295 INSERM University of Toulouse, Toulouse, France.
  • Department of Clinical Pharmacy, Toulouse University Hospital, Toulouse, France.
  • Department of Internal and Geriatric Medicine, Toulouse University Hospital, Toulouse, France.
  • IRMB, University of Montpellier, INSERM UMR 1183, Montpellier, France.
  • Buck AI Platform, Buck Institute for Research on Aging, Novato, California.

Zitieren

APA

Rouch, L., De Souto Barreto, P., Rolland, Y., Guyonnet, S., Cestac, P., Lu, W. H., Lemaitre, J. M., Bensadoun, P., Furman, D., Vellas, B., Andrieu, S., & IHU HealthAge INSPIRE/Open Science group (2026). Accelerated Epigenetic and Inflammatory Aging and Intrinsic Capacity. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2026.24102

Vancouver

Rouch L, De Souto Barreto P, Rolland Y, Guyonnet S, Cestac P, Lu WH, et al. Accelerated Epigenetic and Inflammatory Aging and Intrinsic Capacity. JAMA Network Open. 2026. doi:10.1001/jamanetworkopen.2026.24102

BibTeX
@article{Rouch2026,
  author = {Rouch, Laure and De Souto Barreto, Philipe and Rolland, Yves and Guyonnet, Sophie and Cestac, Philippe and Lu, Wan-Hsuan and Lemaitre, Jean-Marc and Bensadoun, Paul and Furman, David and Vellas, Bruno and Andrieu, Sandrine and IHU HealthAge INSPIRE/Open Science group, IHU HealthAge INSPIRE/Open Science group},
  title = {Accelerated Epigenetic and Inflammatory Aging and Intrinsic Capacity},
  journal = {JAMA Network Open},
  year = {2026},
  doi = {10.1001/jamanetworkopen.2026.24102}
}
Kostenlos starten →